Status:
COMPLETED
A Feasibility Study of Image Guided Noninvasive Single Fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Metastatic Brain Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Stereotactic radiosurgery (SRS) is a way to accurately treat brain tumors. SRS involves the use of a special head frame to keep the head from moving during treatment. The head frame makes very accurat...
Eligibility Criteria
Inclusion
- Histologically confirmed malignancy with the presence of intraparenchymal brain metastases.
- A diagnostic contrast enhanced MRI demonstrating the presence of brain metastases performed within two weeks prior to registration.
- Age ≥ 18 years.
- Must be scheduled or planning to be scheduled for SRS treatment.
- Karnofsky performance status ≥60.
- Patient must sign a study-specific informed consent form. If the patient's mental status precludes his/her giving informed consent, written informed consent may be given by the patient's legal representative.
Exclusion
- Unable to provide informed consent
- Major medical illness including poor cardiac or pulmonary status which would result in inability of the patient to lie down for the procedure.
- Inability to obtain histologic proof of malignancy.
- Younger than 18 years of age.
- Serum creatinine \> 1.3 mg/dl.
- Karnofsky performance status of ≤50.
- Allergy to either CT or MR contrast dyes.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00610285
Start Date
October 1 2005
End Date
July 1 2010
Last Update
December 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065